Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Discover a study that explored the effects of various metabolic abnormalities, such as central obesity and high blood ...

While beer, soft drinks, milk tea, and ice cream are summertime staples for many, they may contribute to the progression of ...

Learn about 5 liver infections that can hide in your body for decades without symptoms. Discover warning signs and prevention ...

Follow-up reached a median 5.5 years overall. Adverse liver outcomes in question counted cirrhosis, decompensation, ...

A recent Chinese clinical trial published in The BMJ reveals that dapagliflozin, a type 2 diabetes drug, shows promise in ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type ...

Fatty liver disease is emerging as a serious health issue in India, with rising cases among both adults and children. Often ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

Laënnec’s cirrhosis is a progressive liver disease that poses significant health risks. Doctors also refer to it as portal or micronodular cirrhosis. Also known as portal cirrhosis, alcoholic ...

Genomenon, a leading genomic intelligence company, today announced its pivotal role in a newly published study in the Journal of Lipid Research that significantly advances scientific understanding and ...

Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the global population, with prevalence varying by ...